Fitzpatrick, S B <br/><br/>
Moxalactam-tobramycin-resistant Pseudomonas aeruginosa isolates in patients with cystic fibrosis.  [electronic resource] 

 -  Clinical pediatrics  Sep 1983 
 - 628-30 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-9228 
<br/><br/><label>Standard No.: </label>10.1177/000992288302200907  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Anti-Bacterial Agents--administration & dosage<br/>Cephalosporins--administration & dosage<br/>Cephamycins--administration & dosage<br/>Child<br/>Cystic Fibrosis--complications<br/>Drug Resistance, Microbial<br/>Humans<br/>Male<br/>Moxalactam<br/>Pseudomonas Infections--drug therapy<br/>Pseudomonas aeruginosa<br/>Respiratory Tract Infections--complications<br/>Tobramycin--administration & dosage